Treatment of female sexual dysfunction
February 9, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3800038 Novel drug delivery device Drug delivery device Device for delivery of useful agent Method of preparing and administering a foam enema 15-Methyl- and 16-phenoxy-PGF2 , amides Topical application of prostaglandin hypotensive agents 9-Fluoroprostaglandin derivatives, and use as medicinal agents Treatment of psychosexual dysfunctions Treatment of sexual dysfunction Inventors
AssigneeApplicationNo. 501098 filed on 02/09/2000US Classes:514/302Ring oxygen in the bicyclo ring systemExaminersPrimary: Criares, Theodore J.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/44AbstractMethods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives, endothelial-derived relaxation factors, vasoactive intestinal polypeptide agonists, smooth muscle relaxants, leukotriene inhibitors, and others. The formulations are also useful for preventing the occurrence of yeast infections, improving vaginal muscle tone and tissue health, enhancing vaginal lubrication, and minimizing excess collagen deposition. A clitoral drug delivery device is also provided.Other References
Field of SearchRing oxygen in the bicyclo ring system | |
